FIELD: medicine; laboratory diagnostics.
SUBSTANCE: invention can be used for preclinical assessment of fibrosis in patients with postmastectomy syndrome. The levels of hyaluronic acid and N-terminal propeptide of procollagen III in blood serum is determined by enzyme immunoassay. If the level of hyaluronic acid is above 11.9 ng/ml and the level of the N-terminal propeptide of procollagen III is above 16.5 ng/ml, soft tissue fibrosis is diagnosed.
EFFECT: method provides objectivity of diagnostics, allows to identify soft tissue fibrosis at the preclinical stage by quantitative analysis of the level of fibrosis molecules in blood serum.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING SUBCLINICAL DEPRESSION IN PATIENTS WITH POSTMASTECTOMY SYNDROME WITH LESIONS OF THE CENTRAL NERVOUS SYSTEM | 2021 |
|
RU2774834C1 |
| METHOD OF PREDICTING THE DEVELOPMENT OF OCCUPATIONAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PERSONS WORKING UNDER CONDITIONS OF EXPOSURE TO INDUSTRIAL AEROSOLS CONTAINING NANOPARTICLES WITH SILICON | 2023 |
|
RU2803246C1 |
| METHOD FOR DIAGNOSTICS OF NON-DIFFERENTIAL CONNECTIVE TISSUE DYSPLASIA IN PREGNANT WOMEN | 2016 |
|
RU2639820C1 |
| METHOD OF TREATMENT OF MYOCARDIAL FIBROSIS IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2022 |
|
RU2802996C1 |
| METHOD OF TREATING DIFFUSE BENIGN BREAST DYSPLASIA | 2018 |
|
RU2702010C1 |
| METHOD OF PREDICTING DEVELOPMENT OF CRITICAL STENOSIS OF CORONARY ARTERIES IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2550947C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH BREAST CANCER RECEIVING ANTIESTROGENIC THERAPY | 2020 |
|
RU2759233C1 |
| METHOD FOR THE TREATMENT OF LICHEN SCLEROSUS OF THE VULVA IN WOMEN | 2021 |
|
RU2755805C1 |
| METHOD OF THE PREVENTION AND TREATMENT OF POST-MASTECTOMY SYNDROME IN WOMEN WITH BREAST CANCER AFTER RADICAL MASTECTOMY OR ORGAN-PRESERVING SURGERY USING THE "NORDIC WALKING" TECHNIQUE | 2022 |
|
RU2803250C1 |
| METHOD FOR PREDICTING EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PERSONS WORKING UNDER EXPOSURE TO INDUSTRIAL AEROSOLS | 2021 |
|
RU2774206C1 |
